-
Quinolone-resistant neisseria gonorrhea (QRNG) continues to spread with alarming frequency across the United States. Quinolones were first recommended for the treatment of GC by the CDC in 1986.
-
The FDA has approved a new combination product for the treatment of type 2 diabetes mellitus. Sitagliptin, the recently approved dipeptidyl peptidase-4 (DPP-4) inhibitor is combined with metformin in two different dose configurations. Sitagliptin/metformin is marketed by Merck & Co., Inc as Janumet.
-
-
Marcolina ST. Nonpharmacologic management of migraines. Altern Med Alert 2007;10(6):61-65.
-
O'Mathuna DP. Antioxidant vitamins, immunity, and endurance exercise. Altern Med Alert 2007;10(6):66-69.
-
Greenfield RH. Tea time will never be the same again: Tea and milk. Altern Med Alert 2007;10(6):70-71. Greenfield RH. Adults, herbs, and evidence-based medicine. Altern Med Alert 2007;10(6):71-72. Greenfield RH. One does not equal twoCinnamon and diabetes mellitus. Altern Med Alert 2007;10(6):72.
-
National Institutes of Neurological Disorders and Stroke. Migraine headaches. Altern Med Alert 2007;10(suppl 6):S1-S2.
-
-
This pilot study from the Medical and Coronary ICUs at Vanderbilt University Medical Center sought to identify factors associated with the development of symptoms of post-traumatic stress disorder (PTSD) following critical illness.
-
Although prognostic information is viewed as very important to family members of incapacitated, critically ill patients, little is known about what prognostic information clinicians provide during family conferences.
